Inactivated vaccine · VDDBV0772
Note: 5 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT01205581 | Phase 2 | HIV Infections |
| NCT01685372 | Phase 2 | HIV Infections |
| NCT04304768 | Approved | HIV Infections |
| NCT01262846 | Approved | HIV Infections |
| NCT01812980 | Approved | HIV Infections |
| NCT01811823 | Approved | HIV Infections |
| NCT01816464 | Approved | HIV Infections |
| NCT01527825 | Phase 3 | HIV Infections |
| NCT01306669 | Phase 3 | HIV Infections |
| NCT01306682 | Phase 3 | HIV Infections |
| NCT01916759 | — | HIV Infections |